Concepedia

Author

Gregor Habl

Heidelberg UniversityORCID

Also Known As

G Habl, G. Habl, Gregor Habl, Habl G, Jan Oelmann

86

Publications

2.4K

Citations

26

H-Index

63

Concepts

All Affiliations

Heidelberg UniversityGerman Cancer Research CenterUniversity Hospital HeidelbergTechnical University of MunichHeidelberger Institut für Radioonkologie
GH

About

Gregor Habl is an author at Heidelberg University specializing in medicine, health sciences, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

324

2

Health Sciences

8

8

299

3

Engineering

2

2

102

4

Natural Sciences

1

1

22

5

Nursing

1

1

44

Gregor Habl

×

44

Publications

2.1K

Citations

25

H-Index

YearCitations

68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients

Florian Sterzing, Clemens Kratochwil, Hannah Fiedler,

European Journal of Nuclear Medicine and Molecular Imaging

2015

225

Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: First long‐term results

Matthias Uhl, Matthias Mattke, Thomas Welzel,

Cancer

2014

146

<sup>68</sup>Ga‐PSMA‐PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment

Gregor Habl, Katharina Sauter, Kilian Schiller,

The Prostate

2017

105

High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: First report of long‐term results

Matthias Uhl, Matthias Mattke, Thomas Welzel,

Cancer

2014

104

Integration of 68Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study

Sabrina Dewes, Kilian Schiller, Katharina Sauter,

Radiation Oncology

2016

91

Rotational IMRT techniques compared to fixed gantry IMRT and Tomotherapy: multi-institutional planning study for head-and-neck cases

Tilo Wiezorek, Tim Brachwitz, Dietmar Georg,

Radiation Oncology

2011

85

Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis

Falk Roeder, Alexis Ulrich, Gregor Habl,

BMC Cancer

2014

85

A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma

Falk Roeder, Daniela Schulz–Ertner, Anna Nikoghosyan,

BMC Cancer

2012

84

PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer

Ali Afshar‐Oromieh, Uwe Haberkorn, Boris Hadaschik,

European Journal of Nuclear Medicine and Molecular Imaging

2013

80

Detection Efficacy of Hybrid <sup>68</sup>Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria

Ingo Einspieler, Isabel Rauscher, Charlotte Düwel,

Journal of Nuclear Medicine

2017

80

Page 1